Join
Search

Posts Tagged ‘FDA’

Fixing an Obama Administration Mistake on Emergency Contraception and Science

Today marks the one-year anniversary of the Obama administration’s decision to prevent the FDA from using the best available science in evaluating the emergency contraception drug Plan B. It was a setback in the Obama administration’s pledge to restore science to its rightful place and listen to scientists “even when it is inconvenient–especially when it is inconvenient.” In the interim, evidence has been mounting that the administration’s decision has placed unnecessary barriers to access to Plan B. It’s time for the administration to allow the FDA to revisit the decision. Read More

Bookmark and Share

Congress Does Something Right — For Federal Scientists

Today, Congress did something good for the American public and good for science. After a 14-year struggle, the House and Senate approved a bipartisan whistleblower protection bill that will make a difference to all federal workers, but that should be especially welcomed by federal scientists. Read More

Bookmark and Share

Woody Guthrie’s Birthday and the War on Cynicism

In our fight for a better quality of life for all Americans, we need storytellers. We need to reach people through personal anecdotes, through editorial cartoons, through songs. We need to arm people with narratives of what is possible, so that together we may be successful in spurning the cynicism that supports the status quo and disillusions the disempowered. And few have done this better than the man who would have turned 100 years old tomorrow: songwriter and American folk hero Woody Guthrie.

But what do Woody’s writings have to do with science? As it turns out, plenty. Read More

Bookmark and Share

The Future Health of Scientific Integrity is at Stake in New FDA Law

The news these days has rightly focused on the Supreme Court’s landmark decision on access to health care.  But with scant media attention, Congress on June 26 sent a bill to the President that is just as important  to the health and well-being of each and every American family, and the future of scientific integrity at the Food and Drug Administration. Read More

Bookmark and Share

We Found Independent Experts—the FDA Can Too

Pharmaceutical and medical device companies, and some in Congress, argue that it’s difficult to find independent experts to serve on FDA’s scientific advisory committees due to strong financial conflict of interest standards.

Our experience proves otherwise. Read More

Bookmark and Share

New Report Details What Should Happen When Scientists at FDA Disagree

Should scientists at the Food and Drug Administration be able to have honest disputes with their colleagues about the science behind a drug or medical device approval decision? Or should they keep quiet about their concerns, preferring not to rock the boat? Read More

Bookmark and Share

For Sara, Faulty Medical Device Leads to Unnecessary, Invasive Surgery

Along with Gwen, Elsa, and Henry, another UCS supporter shared his family’s experiences with unsafe drugs and medical devices: John M’s daughter, Sara, has had needless complications with medical devices in her heart. Read More

Categories: Scientific Integrity  

Tags: , ,   

Bookmark and Share

Study: FDA is Faster than Europe, Canada in Drug Approvals

In the New England Journal of Medicine this week, scientists from Yale University published research finding that the Food and Drug Administration approves drugs faster than its counterparts in Canada and Europe. (Media coverage is here and here.) The study reinforces the fact that FDA can approve drugs with relative speed while putting the safety of Americans first. Read More

Categories: Scientific Integrity  

Tags: , ,   

Bookmark and Share

Senate Does the Right Thing for Whistleblowers – So Close to a Win-Win-Win

At last, a bit of good news and a glimmer of hope from Congress. Last Tuesday evening (May 8), the Senate unanimously approved S. 743, the Whistleblower Protection Enhancement Act. Read More

Bookmark and Share

New Executive Order Could Limit Ability of U.S. Science Agencies to Protect the Public

It is ironic that 50 years after the drug thalidomide was found to have caused serious harm to tens of thousands of babies in Europe and Great Britain, but not the U.S., both the Administration and Congress are backing efforts that could unravel the safety net and erode the power of American agencies to protect public health and safety. Read More

Bookmark and Share